Cancer: A cell cycle defect

Radiography

Volumn 14, Issue 2, 2008, Pages 144-149

  Foster, Irene ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

Apoptosis; Cell cycle regulation; G1 S phase checkpoints; G2 M phase checkpoints; Growth arrest; p53

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOPLASM PROTEIN; PROTEIN P15; PROTEIN P16; PROTEIN P18; PROTEIN P19; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN P57;

BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; GENE AMPLIFICATION; GLIOMA; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SARCOMA; TUMOR SUPPRESSOR GENE;

EID: 40849130946     PISSN: 10788174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radi.2006.12.001     Document Type: Review

References (34)

1. Bergman P.J., and Harris D. Radioresistance, chemoresistance and apoptosis resistance. The past, present and future. Vet Clin North Am Small Anim Pract 27 1 (1997) 47-57
2. Story M., and Kodym R. Signal transduction during apoptosis; implications for cancer therapy. Front Biosci (1998) 365-375
3. Vermeulen K., van Bockstaele D.R., and Berneman Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36 (2003) 131-149
4. McDonnell, Meyn R.E., and Robertson L.E. Implications of apoptotic cell death regulation in cancer therapy. Cancer Biother 6 (1995) 53-60
5. Molinari M. Cell cycle checkpoints and their activation in human cancer. Cell Prolif 33 (2000) 261-274
6. Dixon S., Soriano B.J., Lush R.M., Bomer M.M., and Figg W.D. Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target. The Ann of Pharmco 31 (Jan 1997) 76-81
7. King R.J.B. Cancer biology (1996), Longman
8. Guimarães C.A., and Linden R. Apoptosis and alternative deathstyles. Eur J Biochem 271 (2004) 1638-1650
9. Harms-Ringdahl M., Nicotera P., and Radford J.R. Radiation induced apoptosis. Mutat Res 366 (1996) 171-179
10. Vermeulen K., Berneman Z.N., and van Bockstaele D.R. Cell cycle and apoptosis. Cell Prolif 36 (2003) 165-175
11. Bellamy C.O.C. p53 and apoptosis. Br Med Bull 53 3 (1996) 522-538
12. Kirsch D.G., and Kastan M.B. Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol 16 9 (1998) 3158-3168
13. In: DeVita Jr. V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer: principles and practice of oncolgy. 5th ed. (1997), Lippincott-Raven, Philadelphia
14. Hartwell L.H., and Kastan M.B. Cell cycle and cancer. Science 266 (1994) 1821-1828
15. Liebermann D.A., Hoffman B., and Steinman R.A. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11 (1995) 199-210
16. Weinberg R.A. How cancer arises. Sci Am (1996) 32-40
17. Fearson E. Human cancer syndromes: clues to the origin and nature of cancer. Science 278 (1997) 1043-1050
18. Wang X., and Ohnishi T. p53-dependent signal transduction induced by stress. J Radiat Res 38 (1997) 179-194
19. Weinberg R.A. Tumor supressor genes. Science 254 (1991) 1138-1145
20. Evan G., and Littlewood T. A matter of life and cell death. Science 281 (1998) 1317-1321
21. Arima Y., Hirota T., Bronner C., Mousli M., Fujiwara T., Niwa S., et al. Down regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1 - dependent DNA damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells 9 (2004) 131-142
22. Dang T., Bao S., and Wang X. Human Rad9 is required for the activation of S-phase checkpoint and the maintenance of chromosomal stability. Genes Cells 10 (2005) 287-295
23. Latham K., Baker G.L., Musunuru K., Chen Y.L., Eastman S.W., Wong A., et al. Cell cycle control and differentiation: mechanisms of proliferative dysfunction in cancer cells. Cancer Detect Prev 20 5 (1996)
24. Kam P.C., and Ferch N.I. Apoptosis: mechanisms and clinical implications. Anaesthesia 55 (2000) 1081-1093
25. Taya Y. Rb kinases and Rb-binding proteins: new points of view. TIBS (1997)
26. Decuadin D., Geley S., Hirsch T., Castedo M., Marchetti P., Macho A., et al. Bcl-2 and Bcl-xL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 52 (1997) 62-67
27. Green D.R. A Myc-induced apoptosis pathway surfaces. Science 278 (1997) 1246-1247
28. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 75 (1997) 1129-1136
29. Sattler M., Liang H., Nettesheim D., Meadows R.P., Harlan J.E., Eberstadt M., et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275 (1997) 983-986
30. Hattori H., Kuroda M., Ishida T., Shinmura K., Nagal S., Mukal K., et al. Human DNA damage checkpoints and their relevance to soft tissue sarcoma. Pathol Int 54 (2004) 26-31
31. Marumoto T., Hirota T., Morisaki T., Kunitoku N., Zhang D., Ichikawa Y., et al. Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cells 7 (2002) 1173-1182
32. Golias C., Charalabopoulos A., and Charalabopoulos K. Cell proliferation and cell cycle control: a mini review. Int J Clin Pract 58 (2004) 1134-1141
33. Deng C., and Scott F. Role of the tumor suppressor gene BRAC1 in genetic stability and mammary gland tumor formation. Oncogene 19 (2000) 1059-1064
34. Blegen H., Einhorn N., Sjövall K., Roschke A., Ghadimi B., McShane L., et al. Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas. Int J Gynecol Cancer 10 (2000) 477-487